ระยะเวลาเริ่มให้ Streptokinase ในโรงพยาบาลสมเด็จพระสังฆราชองค์ที่ 17
คำสำคัญ:
streptokinase, acute ST elevation Ml (STEMI), fast track for acute MI managementบทคัดย่อ
A retrospective study of acute ST elevation myocardial infarction (STEMI) patients was studied from January, 2003 to December, 2003. All STEMI patients were 8 cases, 7 cases received streptokinase. Mean of the duration time to start streptokinase after arrived Somdejprasangkharaj 17 hospital was 147.71 minutes. Fast track for acute MI. management was done and then a prospective study of STEMI patients was studied from January, 2004 to August, 2004. All STEMI patients were 9 cases, 8 cases received streptokinase. Mean of the duration time to start streptokinase alter hospital arrival was 79.88 minutes. In addition to, all STEMI 17 patients studied from January, 2003 to August, 2004 were divided into three groups. First group, 9 cases which received streptokinase after hospital arrival within 1 hour, 7 cases survived, survival rate 77.78% and mean of hospital stays were 5.85 days, 2 cases died at home. Second group 6, cases which received streptokinase after hospital arrival more than 1 hour, 4 cases survived, survival rate 66.67% and mean of hospital stays were 6.25 days, 1 case was referred, 1 case died at hospital. Third group 2 cases which did not received streptokinase, 1 cases survived, survival rate 50% and hospital stays were 6 days, 1 cases died at home. conclusion, STEMI patients received streptokinase within 1 hour were likely to survived more, and hospital stays were less than STEMI patients received streptokinase more than 1 hour or did not receive streptokinase after hospital arrival. Fast track for acute MI management might help to start strepto- kinase faster although this study had a few cases.
Downloads
เผยแพร่แล้ว
How to Cite
ฉบับ
บท
License
ลิขสิทธิ์บทความเป็นของผู้เขียนบทความ แต่หากผลงานของท่านได้รับการพิจารณาตีพิมพ์ลงวารสารแพทย์เขต 4-5 จะคงไว้ซึ่งสิทธิ์ในการตีพิมพ์ครั้งแรกด้วยเหตุที่บทความจะปรากฎในวารสารที่เข้าถึงได้ จึงอนุญาตให้นำบทความในวารสารไปใช้ประโยชน์ได้ในเชิงวิชาการโดยจำเป็นต้องมีการอ้างอิงถึงชื่อวารสารอย่างถูกต้อง แต่ไม่อนุญาตให้นำไปใช้ในเชิงพาณิชย์